Slide 1: Slide 1
Slide 2: Full-Year Results to 30th April 2019
Full-Year Results to 30th April 2019
Slide 3: Disclaimer
Disclaimer The materials being provided to you in connection with this presentation are strictly confidential and intended only for informational purposes and convenient reference. This document has been prepared by Ilika plc (“Ilika”) and is the responsibility of the same and comprises the written
Slide 4: Business overview
Business overview Ilika is a pioneer in solid-state battery technology Page 4
Slide 5: Highlight Summary
Highlight Summary Implementation of Stereax ® thin film development programmes with five commercial partners: Four industrial monitoring applications One medical device Achieving record energy density from ultra-thin cells Launching M50 cells, mm-scale miniature batteries Establishing Stereax ® manu
Slide 6: Stereax Commercial Highlights
Stereax ® Commercial Highlights Delivering a perpetual beacon for high value asset tagging Developing a condition monitor for wind turbine blades Designing a rail-track strain gauge Designing an autonomous environmental sensor card Dispatching batteries for evaluation in miniature medical implants P
Slide 7: Stereax Development Partners
Stereax ® Development Partners Asset tagging Wind turbine condition monitoring Track monitoring Environmental monitoring Biomedical partner Powering medical implants Page 7
Slide 8: Goliath Commercial Highlights
Goliath Commercial Highlights Securing £4.2m of grant funding from the Faraday Battery Challenge to develop large format solid-state cells for automotive In Oct 2018 commencing PowerDrive Line collaboration for rapid charging In Feb 2019 starting MoSeSS collaboration led by McLaren for high-power pe
Slide 9: Goliath Development Partnerships
Goliath Development Partnerships Goliath Development Programme: POWER DRIVE LINE • Establish Ilika as leader in development of manufacturing methods for MOSESS production of solid state batteries • Commercialise the large format solid state battery Lead Partner (Goliath) Framework Page 9
Slide 10: Stereax product evolution
Stereax ® product evolution Goliath Pouch cell Stereax ® Thin film bulk Stereax ® Solid electrolyte materials with Scale Toyota High throughput screening miniature commercial development Commercial Readiness Page 10
Slide 11: Technical Highlights
Technical Highlights Achieving record energy density from ultra-thin cells for medical implants Development of photolithographic methods to produce custom cells compatible with industrial processes In April 2019, launch of mm-scale M50 cells for MedTech Demonstration of ability of P180 cells to with
Slide 12: Stereax road map
Stereax® road map Stereax P180 Extended temperature to+150°C A Stereax M250 BLE compatible Stereax M50 mm-scale launched 2019 LoRaWAN compatible High-energy mm?-scale 2020 Goliath y | Large format NB-loT compatible MedRadio compatible A Goliath Goliath High energy 7 | High power High-density for wea
Slide 13: Stereax product to market mapping
Stereax ® product to market mapping Goliath M50 P180 M250 Key requirements Key requirements Non-flammable Key requirements Bio-compatibility High capacity Key requirements High operating Long life High energy density Long life (10 years) temperature Low leakage High power Integration Long life (10 y
Slide 14: Partner Engagement
Partner Engagement Product Development Technology Transfer Product Manufacturing Engineering Fees License Fees Royalties Page 14
Slide 15: Stereax manufacturing partnerships
Stereax ® manufacturing partnerships M50 Capacity 2019 2020 2021 2022 (Devices/yr) 500 R&D 13,500 Ilika pilot line 312,000 UK manufacturing partnership 1 million+ Large scale Page 15
Slide 16: Stereax commercialisation
Stereax® commercialisation M50 launch Early Deployments Stereax® Agreements (Total) P180 launch M250 launch Lead partner engagement Page 16
Slide 17: Example ROI calculation
Example ROI calculation Implantable blood pressure sensor Income/ (costs) for Ilika Yr 1 Yr2 Yr3 Yr5-10 p.a. $k $k $k $k Development costs (500) (250) Contribution to costs 350 175 Licence issue fee 375 125 Royalties 600 Total (150) 300 125 600 Payback in 18 months ROI 63% using 20% discount rate Vo
Slide 18: Financial summary for the year ended 30th April 2019
Financial summary for the year ended 30th April 2019 Turnover £2.6m (2018: £2.1m) Front end of large format battery developments Loss for the period £2.3m (2018: £2.9m) Staff costs remained level at £2.8m Placing and open offer in the year raised net £4.1m 22.3m shares issued at 20p in July 2018 Los
Slide 19: Summary cash-flow to 30th April 2019
Summary cash-flow to 30th April 2019 £m Opening balance 2.8 Fundraise 4.1 Capex* (1.0) Operating cash outflow (2.2) R&D tax credit 0.3 Closing balance 4.0 *New facility & equipment for large format battery development Page 19
Slide 20: 2019/20 Outlook
2019/20 Outlook Goliath programmes and autonomous sensor deployment to drive revenue growth (order book of £2.7m for 2019/20) Stereax ® manufacturing scale up Focus on converting OEM support into commercial revenue The Board looks forward to further growth in 2019/20 Page 20
Slide 21: Contact details
Contact details www.ilika.com @ilikaplc /ilika-plc Page 21